By Professor Gail Matthews

Journal articles

Lau DTY; Jackson K; Picchio CA; Kramvis A; Sonderup M; Lemoine M; Matthews G; Howell J; Coffin CS; Hellard M; Lee AU; Anderson DA; Kerth HA; Lee EE; Tavis JE; Dandri M; Revill PA; Spearman CW; Penicaud C; Levrero M; El-Sayed M, 2024, 'Availability of point-of-care HBV tests in resource-limited settings', The Lancet Gastroenterology and Hepatology, 9, pp. 1073 - 1076, http://dx.doi.org/10.1016/S2468-1253(24)00308-X

Phetsouphanh C; Jacka B; Ballouz S; Jackson KJL; Wilson DB; Manandhar B; Klemm V; Tan HX; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville SG; Kent SJ; Byrne A; Brew BJ; Darley DR; Dore GJ; Kelleher AD; Matthews GV, 2024, 'Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-47720-8

Hume SJ; Wong DK; Yuen MF; Jackson K; Bonanzinga S; Vogrin S; Hall SAL; Burns GS; Desmond PV; Sundararajan V; Ratnam D; Levy MT; Lubel JS; Nicoll AJ; Strasser SI; Sievert W; Ngu MC; Sinclair M; Meredith C; Matthews G; Revill PA; Littlejohn M; Bowden S; Visvanathan K; Holmes JA; Thompson AJ, 2024, 'High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy', Liver International, 44, pp. 2605 - 2614, http://dx.doi.org/10.1111/liv.16029

Tillakeratne S; Pearson SA; Alavi M; Hajarizadeh B; Martinello M; Law M; George J; Amin J; Matthews G; Grebely J; Dore GJ; Valerio H, 2024, 'Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia', The Lancet Regional Health - Western Pacific, 51, http://dx.doi.org/10.1016/j.lanwpc.2024.101185

Dodd S; Mohebbi M; O'Donohue J; Matthews G; Darley DR; Berk M, 2024, 'Psychiatric sequelae after SARS-Cov-2 infection: Trajectory, predictors and associations in a longitudinal Australian cohort', Acta Neuropsychiatrica, 36, pp. 195 - 210, http://dx.doi.org/10.1017/neu.2023.45

Martinello M; Matthews GV, 2024, 'Reinfection After Hepatitis C Virus Treatment-Keep Testing, Keep Treating', JAMA network open, 7, pp. e2430290, http://dx.doi.org/10.1001/jamanetworkopen.2024.30290

Harney BL; Sacks-Davis R; Traeger M; van Santen DK; Wilkinson AL; Asselin J; Fairley CK; Roth N; Bloch M; Matthews G; Donovan B; Guy R; Hellard ME; Doyle JS, 2024, 'Annual hepatitis C testing and positive tests among gay and bisexual men in Australia from 2016 to 2022: a serial cross-sectional analysis of sentinel surveillance data', Sexually Transmitted Infections, 100, pp. 295 - 301, http://dx.doi.org/10.1136/sextrans-2024-056175

Matthews G; Jacoby S; Borok M; Eriobu N; Kaplan R; Kumarasamy N; Bennet JA; Avihingsanon A; Chetchotisakd P; Wagner Cardoso S; Azwa I; Losso M; Brown D; Arlinda D; Hutchinson J; Kelleher A; Cisse M; Dao S; Polizzotto M; Emery S; Law M; Papot E; Karyana M; Lupo S; Solari AM; Grinsztejn B; Wolff M; Andrade-Villanueva J; Mosqueda Gómez JL; Chow TS; Mohapi L; Yunihastuti E; Hadi U; Katu S; Subronto YW; Lane HC; Perelis L, 2024, 'Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D²EFT): an open-label, randomised, phase 3b/4 trial', The Lancet HIV, 11, pp. e436 - e448, http://dx.doi.org/10.1016/S2352-3018(24)00089-4

Valerio H; Alavi M; Marshall AD; Hajarizadeh B; Amin J; Law M; Tillakeratne S; George J; Degenhardt L; Grebely J; Matthews GV; Dore GJ, 2024, 'Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based study', Drug and Alcohol Review, 43, pp. 1080 - 1092, http://dx.doi.org/10.1111/dar.13688

Stewardson AJ; Davis JS; Dunlop AJ; Tong SYC; Matthews GV, 2024, 'How I manage severe bacterial infections in people who inject drugs', Clinical Microbiology and Infection, 30, pp. 877 - 882, http://dx.doi.org/10.1016/j.cmi.2024.01.022

Marshall AD; Willing AR; Kairouz A; Cunningham EB; Wheeler A; O'Brien N; Perera V; Ward JW; Hiebert L; Degenhardt L; Hajarizadeh B; Colledge S; Hickman M; Jawad D; Lazarus JV; Matthews GV; Scheibe A; Vickerman P; Dore GJ; Grebely J; Sargsyants N; Suleymanova L; Salkic N; Simonova M; Nemeth-Blazic T; Mravcik V; Kivimets K; Salupere R; Butsashvili M; Soselia G; Makara M; Tolmane I; Jancorienė L; Stratulat S; Flisiak R; Gheorghe L; Cernat R; Lakhov A; Stanevich O; Jarcuska P; Peck-Radosavljevic M; Robaeys G; Øvrehus A; Foster G; Sutinen J; Farkkila M; Rautiainen H; Vuoti S; Nikolova D; Pawlotsky JM; Rockstroh J; Sypsa V; Papatheodoridis G; Olafsson S; Feeney E; Teti E; Seguin-Devaux C; Pocock J; Reiff S; McDougall N; Van der Valk M; Dalgard O; Tato Marinho R; Dillon J; Peters E; Bojovic K; Matičič M; Kåberg M; Bruggmann P; Healy B; Chong VH; Yi S; Tucker J; Pasaribu LR; Tanaka J; Ashley EA; Abu Hassan MR; Mohammed NS; Chan HK; Gidaagaya S; Kyi KP; Hyung Joon K; Chin B; Baladjay PC; Kao JH; Wansom T; da Cruz B; Flower B; Ehsan E; Al Mahtab M; Khandu L; Bhadoria AS; Alavi M; KC P; Hamid S; Biryukov S; Alymbaeva D; Alaei A; Bakieva S; Flichman D, 2024, 'Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions', The Lancet Gastroenterology and Hepatology, 9, pp. 366 - 382, http://dx.doi.org/10.1016/S2468-1253(23)00335-7

Harney BL; Sacks-Davis R; van Santen DK; Traeger MW; Wilkinson AL; Asselin J; Fairley CK; Roth N; Bloch M; Matthews GV; Donovan B; Guy R; Stoové M; Hellard ME; Doyle JS, 2024, 'Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020', Liver International, 44, pp. 1024 - 1031, http://dx.doi.org/10.1111/liv.15841

Singh KP; Avihingsanon A; Zerbato JM; Zhao W; Braat S; Tennakoon S; Rhodes A; Matthews GV; Fairley CK; Sasadeusz J; Crane M; Audsley J; Lewin SR, 2024, 'Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy', eBioMedicine, 102, http://dx.doi.org/10.1016/j.ebiom.2024.105054

Harney BL; Sacks-Davis R; Agius P; van Santen DK; Traeger MW; Wilkinson AL; Asselin J; Fairley CK; Roth N; Bloch M; Matthews GV; Donovan B; Guy R; Stoové M; Hellard ME; Doyle JS; Aung HL; Baillie G; Bastian L; Bateson D; Boyd M; Carter A; Cogle A; Costello J; Dimech W; El-Hayek C; Ellard J; Franklin L; Hocking J; Kim J; Nguyen L; Nguyen T; Nolan D; O’Connor C; Patel P; Pendle S; Polkinghorne V; Reed P; Ryder N; Selvey C; Walker M; Watson N, 2024, 'Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae099

Bin Usman Shah SH; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ, 2024, 'Corrigendum to “Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales” [JHEP Reports 4 (2022)] (JHEP Reports (2022) 4(10), (S2589555922001240), (10.1016/j.jhepr.2022.100552))', JHEP Reports, 6, http://dx.doi.org/10.1016/j.jhepr.2024.101022

Sacks-Davis R; van Santen DK; Boyd A; Young J; Stewart A; Doyle JS; Rauch A; Mugglin C; Klein M; van der Valk M; Smit C; Jarrin I; Berenguer J; Lacombe K; Requena MB; Wittkop L; Leleux O; Bonnet F; Salmon D; Matthews GV; Guy R; Martin NK; Spelman T; Prins M; Stoove M; Hellard M; Ke T; Zhang Y; Pedrana A; Asselin J; Dawe J; Wilkinson A; Schinkel J; Sogni P; Esterle L; Gilbert C; Merchadou L; Gillet S; Khan C; Le Marec F; Perrier A; Shaw I; Martinello M; Applegate T; Carson J; Harney B; Bryant M; Jarrin Vera I; Alejos B; Lazarus JV; Moreno C; Izquierdo R; Rava M; Wang S; Lumia J; Pexos C; Peiris H; Saeed S; Moodie E; Pick N; Conway B; Hull M; Wong A; Gill J; Barrett L; Cohen J; Cox J; Cote P; Haider S; Rouleau D; Vachon ML; Rachlis A; Sandre R; Walmsley S; Sadr A; Cooper C; Sanche S; Salazar-Viscaya L; Kusejko K; Hage K; Requena MB; Girard PM; Brucker M; Vincensini JP, 2024, 'Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies', The Lancet HIV, 11, pp. e106 - e116, http://dx.doi.org/10.1016/S2352-3018(23)00267-9

van Santen DK; Stewart A; Doyle JS; Stoové MA; Asselin J; Klein MB; Young J; Berenguer J; Jarrin I; Lacombe K; Wittkop L; Leleux O; Salmon D; Bonnet F; Rauch A; Mugglin C; Matthews G; Prins M; Smit C; Boyd A; van der Valk M; Sacks-Davis R; Hellard ME, 2024, 'Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)', International Journal of Epidemiology, 53, http://dx.doi.org/10.1093/ije/dyad154

Shah SHBU; Valerio H; Hajarizadeh B; Matthews G; Alavi M; Dore GJ, 2023, 'Cascade of care among people with hepatitis B in New South Wales, Australia', Journal of Viral Hepatitis, 30, pp. 926 - 938, http://dx.doi.org/10.1111/jvh.13881

Matuozzo D; Talouarn E; Marchal A; Zhang P; Manry J; Seeleuthner Y; Zhang Y; Bolze A; Chaldebas M; Milisavljevic B; Gervais A; Bastard P; Asano T; Bizien L; Barzaghi F; Abolhassani H; Abou Tayoun A; Aiuti A; Alavi Darazam I; Allende LM; Alonso-Arias R; Arias AA; Aytekin G; Bergman P; Bondesan S; Bryceson YT; Bustos IG; Cabrera-Marante O; Carcel S; Carrera P; Casari G; Chaïbi K; Colobran R; Condino-Neto A; Covill LE; Delmonte OM; El Zein L; Flores C; Gregersen PK; Gut M; Haerynck F; Halwani R; Hancerli S; Hammarström L; Hatipoğlu N; Karbuz A; Keles S; Kyheng C; Leon-Lopez R; Franco JL; Mansouri D; Martinez-Picado J; Metin Akcan O; Migeotte I; Morange PE; Morelle G; Martin-Nalda A; Novelli G; Novelli A; Palabiyik F; Pan-Hammarström Q; de Diego RP; Planas-Serra L; Pleguezuelo DE; Prando C; Pujol A; Reyes LF; Rivière JG; Rodriguez-Gallego C; Rojas J; Rovere-Querini P; Schlüter A; Shahrooei M; Sobh A; Soler-Palacin P; Tandjaoui-Lambiotte Y; Tipu I; Tresoldi C; Troya J; van de Beek D; Zatz M; Zawadzki P; Al-Muhsen SZ; Alosaimi MF; Alsohime FM; Baris-Feldman H; Butte MJ; Constantinescu SN; Cooper MA; Dalgard CL; Fellay J; Heath JR; Lau YL; Lifton RP; Maniatis T; Mogensen TH; von Bernuth H; Lermine A; Vidaud M; Boland A, 2023, 'Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19', Genome Medicine, 15, http://dx.doi.org/10.1186/s13073-023-01173-8

Smith MZ; Turner M; Haurat J; Thevarajan I; Denholm J; Tong SY; Matthews GV; Bull RA; Martinello M; McMahon J; Imrie A; Pillai PE, 2023, 'The APPRISE Virtual Biobank for Infectious Diseases', Communicable diseases intelligence (2018), 47, http://dx.doi.org/10.33321/cdi.2023.47.66

Dharan NJ; Sasson SC; Ahlenstiel G; Andersen CR; Bloch M; Buckland G; Hamad N; Han WM; Kelleher AD; Long GV; Matthews GV; Mina MM; Papot E; Petoumenos K; Swaminathan S; Withers B; Yun J; Polizzotto MN, 2023, 'Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0289907

Martinello M; Bhagani S; Shaw D; Orkin C; Cooke G; Gane E; Iser D; Ustianowski A; Kulasegaram R; Stedman C; Tu E; Grebely J; Dore GJ; Nelson M; Matthews GV, 2023, 'Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study', JHEP Reports, 5, http://dx.doi.org/10.1016/j.jhepr.2023.100867

Martinello M; Carson JM; Van Der Valk M; Rockstroh JK; Ingiliz P; Hellard M; Nelson M; Lutz T; Bhagani S; Kim AY; Hull M; Cordes C; Moon J; Feld JJ; Gane E; Rauch A; Bruneau J; Tu E; Applegate T; Grebely J; Dore GJ; Matthews GV, 2023, 'Reinfection incidence and risk among people treated for recent hepatitis C virus infection', AIDS, 37, pp. 1883 - 1890, http://dx.doi.org/10.1097/QAD.0000000000003651

Hage K; van de Kerkhof M; Boyd A; Carson JM; Newsum AM; Matser A; van der Valk M; Brinkman K; Arends JE; Lauw FN; Rijnders BJA; van Eeden A; Martinello M; Matthews GV; Schinkel J; Prins M, 2023, 'Screening for Hepatitis C Virus Reinfection Using a Behaviour-Based Risk Score among Men Who Have Sex with Men with HIV: Results from a Case–Control Diagnostic Validation Study', Pathogens, 12, pp. 1248, http://dx.doi.org/10.3390/pathogens12101248

Carson JM; Barbieri S; Cunningham E; Mao E; van der Valk M; Rockstroh JK; Hellard M; Kim A; Bhagani S; Feld JJ; Gane E; Thurnheer MC; Bruneau J; Tu E; Dore GJ; Matthews GV; Martinello M, 2023, 'Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study', Journal of the International AIDS Society, 26, pp. e26168, http://dx.doi.org/10.1002/jia2.26168

Martinello M; Naggie S; Rockstroh JK; Matthews GV, 2023, 'Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative Review', Clinical Infectious Diseases, 77, pp. S238 - S244, http://dx.doi.org/10.1093/cid/ciad344

Thompson AJ; Jackson K; Bonanzinga S; Hall SAL; Hume S; Burns GS; Sundararajan V; Ratnam D; Levy MT; Lubel J; Nicoll AJ; Strasser SI; Sievert W; Desmond PV; Ngu MC; Sinclair M; Meredith C; Matthews G; Revill PA; Littlejohn M; Bowden DS; Canchola JA; Torres J; Siew P; Lau J; Brot BL; Kuchta A; Visvanathan K, 2023, 'Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants', Hepatology Communications, 7, http://dx.doi.org/10.1097/HC9.0000000000000188

Koopsen J; Matthews G; Rockstroh J; Applegate TL; Bhagani S; Rauch A; Grebely J; Sacks-Davis R; Ingiliz P; Boesecke C; Rebers S; Feld J; Bruneau J; Martinello M; Hellard M; Dore GJ; Schinkel J; van der Valk M; Adams T; Amjad S; Appelhans C; Becker B; Bouchard R; Braun D; Bruelisauer C; Calcagnile S; Carroll A; Cerocchi O; Chronister K; Cordes C; Dore G; Evans F; Fedele S; Ferguson C; Fraser C; Ganase B; Gane E; George V; Gerlach C; Gilleece Y; Gilliver R; Grube C; Gustafson J; Haas A; Hagenauer M; Harris M; Helder J; Hirter D; Hull M; Katz S; Kim A; Kotsoros B; Lacalamita M; Lindergard G; Lutz T; Macabodbod L; Manz M; Marks P; Messina P; Mohrmann K; Monnich C; Moon J; Moriggia A; Morris G; Morrish T; Nelson M; Oliver V; Patterson J; Peters M; Petoumenos K; Porretta H; Raymode P; Read P; Reece S; Saidi A; Sasadeusz J; Scherler P; Schröder R; Selfridge M; Sevehon A; Shaw D; Sulkowski M; Tamaddoni M; Thunder O; Thurnheer MC; Tu E; Ustianowski A; Witele E, 2023, 'Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis', The Lancet Microbe, 4, pp. e622 - e631, http://dx.doi.org/10.1016/S2666-5247(23)00108-8

Cysique LA; Jakabek D; Bracken SG; Allen-Davidian Y; Heng B; Chow S; Dehhaghi M; Staats Pires A; Darley DR; Byrne A; Phetsouphanh C; Kelleher A; Dore GJ; Matthews GV; Guillemin GJ; Brew BJ, 2023, 'The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC', Annals of Clinical and Translational Neurology, 10, pp. 1338 - 1352, http://dx.doi.org/10.1002/acn3.51825

Shah SHBU; Alavi M; Hajarizadeh B; Matthews G; Valerio H; Dore GJ, 2023, 'Liver-related mortality among people with hepatitis B and C: Evaluation of definitions based on linked healthcare administrative datasets', Journal of Viral Hepatitis, 30, pp. 520 - 529, http://dx.doi.org/10.1111/jvh.13824

Cheng Q; Cunningham EB; Shih S; Amin J; Bruneau J; Artenie AA; Powis J; Litwin AH; Cooper C; Dalgard O; Hellard M; Bruggmann P; Marks P; Lacombe K; Stedman C; Read P; Hajarizadeh B; Dunlop AJ; Conway B; Feld JJ; Dore GJ; Grebely J; Dore G; Crawford S; Swan T; Byrne J; Coordinating Centre—Amanda Erratt ML; Marks P; Shaw I; Siriragavan S; Quiene S; Petoumenos K; Schmid P; Castro E; Moriggia A; Daulouede JP; Fraser C; Feld J; Gane E; Matthews G; Kronborg I; Shaw D; Norton B; Thurnheer MC; Weltman M; Dillon J; Kessler S; Knapp C; Oprandi L; Messina P; Pantic M; Le Cam M; Maitre C; Andreassen J; Melkeraaen I; Tollefsen MM; Pagarigan H; Milne R; Mason K; Kaznowski D; Zou L; Bouchard R; Kotsoros B; Muir M; Milloy J; Oliver V; Noonan T; Sevehon A; Hazelwood S; Hall M; Hagenauer M; Liddle R; Ferguson C; Agyemang L; Patel H; Soloway I; Cerocchi O; Lacalamita M; Fragomeli V; Gilliver R; Lothian R; Cleary S; Johnston L; Middleton S; D'Amico R; McGovern B; Anderson J; Zhong Z; Keane F; Tatsch F; Brainard D; McHutchison J, 2023, 'Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs', Value in Health, 26, pp. 883 - 892, http://dx.doi.org/10.1016/j.jval.2022.12.016

Carson JM; Barbieri S; Matthews GV; Dore GJ; Hajarizadeh B, 2023, 'Corrigendum to ‘National trends in retreatment of HCV due to reinfection or treatment failure in Australia’ (J Hepatol [2023] 260–270) (Journal of Hepatology (2023) 78(2) (260–270), (S016882782203118X), (10.1016/j.jhep.2022.09.011))', Journal of Hepatology, 78, pp. 1084, http://dx.doi.org/10.1016/j.jhep.2023.02.020

Akerman A; Milogiannakis V; Jean T; Esneau C; Silva MR; Ison T; Fichter C; Lopez JA; Chandra D; Naing Z; Caguicla J; Li D; Walker G; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Foster CSP; Sato K; Lee S; Song Y; Mao L; Sigmund A; Phu A; Vande More AM; Hunt S; Douglas M; Caterson I; Britton W; Sandgren K; Bull R; Lloyd A; Triccas J; Tangye S; Bartlett NW; Darley D; Matthews G; Stark DJ; Petoumenos K; Rawlinson WD; Murrell B; Brilot F; Cunningham AL; Kelleher AD; Aggarwal A; Turville SG, 2023, 'Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level', eBioMedicine, 90, http://dx.doi.org/10.1016/j.ebiom.2023.104545

Manoharan L; Latham NH; Munari SC; Traeger MW; Menon V; Luhmann N; Baggaley R; Macdonald V; Verster A; Siegfried N; Matthews GV; Stoové M; Hellard ME; Doyle JS, 2023, 'Immediate treatment for recent hepatitis C infection in people with high-risk behaviors: a systematic review and meta-analysis', Hepatology Communications, 7, http://dx.doi.org/10.1097/HC9.0000000000000082

Carson J; Barbieri S; Matthews GV; Dore GJ; Hajarizadeh B, 2023, 'Increasing national trend of direct-acting antiviral discontinuation among people treated for HCV 2016-2021', Hepatology Communications, 7, pp. e0125, http://dx.doi.org/10.1097/HC9.0000000000000125

Isfordink CJ; Boyd A; Sacks-Davis R; van Santen DK; Smit C; Martinello M; Stoove M; Berenguer J; Wittkop L; Klein MB; Rauch A; Salmon D; Lacombe K; Stewart A; Schinkel J; Doyle JS; Hellard M; van der Valk M; Matthews GV, 2023, 'Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study', The Lancet Public Health, 8, pp. e294 - e304, http://dx.doi.org/10.1016/S2468-2667(23)00056-7

Anagnostou N; Archuleta S; Athan E; Barina L; Best E; Bloomfield M; Bostock J; Botheras C; Bowen A; Britton P; Burden H; Campbell A; Carter H; Cheng M; Chew KL; Chong IRLM; Coombs G; Daley P; Daneman N; Davies J; Davis J; Dishon-Benattar Y; Dotel R; Dunlop A; Flack F; Flanagan K; Foo H; Ghanem-Zoubi N; Giulieri S; Goodman A; Grant J; Gregson D; Guy S; Gwee A; Hardy E; Henderson A; Heriot G; Howden B; Hudson F; Johnstone J; Kalimuddin S; de Kretser D; Kwa A; Lee T; Legg A; Lewis R; Llewelyn M; Lumley T; Lye D; MacFadden D; Mahar R; Malhame I; Marks M; Marsh J; Martinello M; Matthews G; McArthur C; McGlothlin A; McKew G; McMullan B; McQuilten Z; Milliken E; Mora J; Morpeth S; Murthy S; Nourse C; O'Sullivan M; Paterson D; Paul M; Petersiel N; Petrella L; Pett S; Price D; Roberts J; Robinson JO; Rogers B; Saville B; Scarborough M; Scheetz M; Scheuerman O; Schwartz K; Smith S; Snelling T; Soares M; Sommerville C; Stewardson A; Stone N; Sud A; Tilley R; Tong S; Turner R; Underwood J; van Hal S; Voss L; Walls G; Webb R; Webb S; Whiteway L; Wilson H; Wuerz T; Yahav D, 2023, 'The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe (vol 75, pg 2027, 2022)', CLINICAL INFECTIOUS DISEASES, http://dx.doi.org/10.1093/cid/ciac730

Nyein PP; Tillakeratne S; Phyu S; Yee MM; Lwin MM; Htike KL; Aung MT; Grebely J; Applegate T; Hanson J; Matthews G; Lin KS, 2023, 'Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in Myanmar', Viruses, 15, pp. 521, http://dx.doi.org/10.3390/v15020521

Carson JM; Barbieri S; Matthews GV; Dore GJ; Hajarizadeh B, 2023, 'National trends in retreatment of HCV due to reinfection or treatment failure in Australia', Journal of Hepatology, 78, pp. 260 - 270, http://dx.doi.org/10.1016/j.jhep.2022.09.011

van Santen DK; Sacks-Davis R; Stewart A; Boyd A; Young J; van der Valk M; Smit C; Rauch A; Braun DL; Jarrin I; Berenguer J; Lazarus JV; Lacombe K; Requena MB; Wittkop L; Leleux O; Salmon D; Bonnet F; Matthews G; Doyle JS; Spelman T; Klein MB; Prins M; Asselin J; Stoové MA; Hellard M, 2023, 'Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019', eClinicalMedicine, 56, http://dx.doi.org/10.1016/j.eclinm.2022.101810

Schiavone B; Dore GJ; Stone E; Matthews GV; Darley DR, 2023, 'An update on long COVID and its management', Medicine Today, 24, pp. 37 - 43

Jessica HB; Carson J; Scott M; Patricia C; Nelson R; Helen VG; Phillip R; Hanson J; Robert M; Matthews G; Dore GJ; Martinello M; Read P, 2023, 'Effectiveness of direct-acting antiviral therapy among Aboriginal and Torres Strait Islander peoples with HCV infection in Australia: A national real-world cohort (REACH-C)', Journal of Viral Hepatitis, 30, pp. 386 - 396, http://dx.doi.org/10.1111/jvh.13803

Hall SAL; Burns GS; Mooney BJ; Millen R; Morris R; Vogrin S; Sundararajan V; Ratnam D; Levy MT; Lubel JS; Nicoll AJ; Strasser SI; Sievert W; Desmond PV; Ngu MC; Angus P; Sinclair M; Meredith C; Matthews G; Revill PA; Jackson K; Littlejohn M; Bowden S; Locarnini SA; Thompson AJ; Visvanathan K, 2023, 'Hepatitis B Virus Flares after Nucleot(s)ide Analogue Cessation Are Associated with Activation of Toll-Like Receptor Signaling Pathways', Journal of Infectious Diseases, 227, pp. 123 - 132, http://dx.doi.org/10.1093/infdis/jiac375

Casey JL; Dore GJ; Grebely J; Matthews GV; Cherepanov V; Martinello M; Marks P; Janssen HLA; Hansen BE; Kaul R; MacParland SA; Gehring AJ; Feld JJ, 2023, 'Hepatitis C virus-specific immune responses following direct-acting antivirals administered during recent hepatitis C virus infection', Journal of Viral Hepatitis, 30, pp. 64 - 72, http://dx.doi.org/10.1111/jvh.13761

Morpeth SC; Venkatesh B; Totterdell JA; McPhee GM; Mahar RK; Jones M; Bandara M; Barina LA; Basnet BK; Bowen AC; Burke AJ; Cochrane B; Denholm JT; Dhungana A; Dore GJ; Dotel R; Duffy E; Dummer J; Foo H; Gilbey TL; Hammond NE; Hudson BJ; Jha V; Jevaji PR; John O; Joshi R; Kang G; Kaur B; Kim S; Das SK; Lau JSY; Littleford R; Marsh JA; Marschner IC; Matthews G; Maze MJ; McArthur CJ; McFadyen JD; McMahon JH; McQuilten ZK; Molton J; Mora JM; Mudaliar V; Nguyen V; O'Sullivan MVN; Pant S; Park JE; Paterson DL; Price DJ; Raymond N; Rees MA; Robinson JO; Rogers BA; Ryu W-S; Sasadeusz J; Shum O; Snelling TL; Sommerville C; Trask N; Lewin SR; Hills TE; Davis JS; Roberts JA; Tong SYC, 2023, 'A Randomized Trial of Nafamostat for Covid-19.', NEJM Evid, 2, pp. EVIDoa2300132, http://dx.doi.org/10.1056/EVIDoa2300132

Usman Shah SHB; Valerio H; Hajarizadeh B; Alavi M; Matthews G; Dore G, 2023, 'Cascade of care among people with an HBV notification in New South Wales, Australia, including diagnosis, specialist assessment, and treatment uptake', Journal of Hepatology, 78, pp. S910 - S910, http://dx.doi.org/10.1016/s0168-8278(23)02932-x

Lundgren JD; Babiker AG; Sharma S; Grund B; Phillips AN; Matthews G; Kan VL; Aagaard B; Abo I; Alston B; Arenas-Pinto A; Avihingsanon A; Badal-Faesen S; Brites C; Carey C; Casseb J; Clarke A; Collins S; Corbelli GM; Dao S; Denning ET; Emery S; Eriobu N; Florence E; Furrer H; Fätkenheuer G; Gerstoft J; Gisslén M; Goodall K; Henry K; Horban A; Hoy J; Hudson F; Azwa RISR; Kedem E; Kelleher A; Kityo C; Klingman K; Rosa AL; Leturque N; Lifson AR; Losso M; Lutaakome J; Madero JS; Mallon P; Mansinho K; Filali KME; Molina J-M; Murray DD; Nagalingeswaran K; Nozza S; Ormaasen V; Paredes R; Peireira LC; Pillay S; Polizzotto MN; Raben D; Rieger A; Sanchez A; Schechter M; Sedlacek D; Staub T; Touloumi G; Turner M; Madruga JV; Vjecha M; Wolff M; Wood R; Zilmer K; Lane HC; Neaton JD; INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group , 2023, 'Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.', NEJM Evid, 2, http://dx.doi.org/10.1056/evidoa2200302

Phetsouphanh C; Khoo WH; Jackson K; Klemm V; Howe A; Aggarwal A; Akerman A; Milogiannakis V; Stella AO; Rouet R; Schofield P; Faulks ML; Law H; Danwilai T; Starr M; Munier CML; Christ D; Singh M; Croucher PI; Brilot-Turville F; Turville S; Phan TG; Dore GJ; Darley D; Cunningham P; Matthews GV; Kelleher AD; Zaunders JJ, 2022, 'High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.1032911

Marshall AD; Matthews GV, 2022, 'Simplifying hepatitis C care models: a crucial step towards hepatitis C elimination', The Lancet Gastroenterology and Hepatology, 7, pp. 1066 - 1068, http://dx.doi.org/10.1016/S2468-1253(22)00306-5

Carson JM; Dore GJ; Lloyd AR; Grebely J; Byrne M; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Matthews GV; Hajarizadeh B, 2022, 'Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study', Clinical Infectious Diseases, 75, pp. 1809 - 1819, http://dx.doi.org/10.1093/cid/ciac246

Back to profile page